Stephens assumed coverage on shares of National Health Investors Inc. (NYSE:NHI) in a report issued on Wednesday. The firm issued an overweight rating and a $84.00 price objective on the real estate investment trust’s stock.

Several other equities analysts have also weighed in on NHI. JMP Securities reiterated a hold rating on shares of National Health Investors in a report on Saturday, June 4th. Wells Fargo & Co. reiterated a hold rating on shares of National Health Investors in a report on Sunday, September 4th. Zacks Investment Research upgraded shares of National Health Investors from a sell rating to a hold rating in a report on Thursday, August 11th. Mizuho upped their price objective on shares of National Health Investors from $66.00 to $77.00 and gave the company a neutral rating in a report on Monday, August 8th. Finally, Cantor Fitzgerald reiterated a hold rating on shares of National Health Investors in a report on Friday, September 9th. Six investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. The company currently has a consensus rating of Hold and an average target price of $74.14.

National Health Investors (NYSE:NHI) opened at 78.65 on Wednesday. The company’s 50-day moving average price is $79.44 and its 200-day moving average price is $72.38. The company has a market cap of $3.08 billion, a PE ratio of 18.14 and a beta of 0.65. National Health Investors has a 12-month low of $54.51 and a 12-month high of $82.53.

National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Friday, August 5th. The real estate investment trust reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.21 by $0.01. National Health Investors had a net margin of 69.69% and a return on equity of 14.68%. The firm had revenue of $61.20 million for the quarter, compared to analyst estimates of $58.08 million. During the same quarter in the prior year, the business earned $1.17 earnings per share. The business’s quarterly revenue was up 8.7% compared to the same quarter last year. Equities analysts anticipate that National Health Investors will post $4.88 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, November 10th. Investors of record on Friday, September 30th will be issued a $0.90 dividend. This represents a $3.60 annualized dividend and a yield of 4.58%. The ex-dividend date is Wednesday, September 28th. National Health Investors’s dividend payout ratio (DPR) is presently 82.95%.

In related news, insider Kristin Sallee Gaines sold 4,044 shares of the firm’s stock in a transaction that occurred on Tuesday, June 28th. The shares were sold at an average price of $73.71, for a total value of $298,083.24. Following the completion of the transaction, the insider now directly owns 53,089 shares of the company’s stock, valued at approximately $3,913,190.19. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Robert A. Mccabe, Jr. sold 800 shares of the firm’s stock in a transaction that occurred on Tuesday, August 30th. The stock was sold at an average price of $80.29, for a total transaction of $64,232.00. Following the completion of the transaction, the director now directly owns 10,021 shares of the company’s stock, valued at $804,586.09. The disclosure for this sale can be found here. 5.74% of the stock is currently owned by corporate insiders.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its position in National Health Investors by 7.4% in the second quarter. Vanguard Group Inc. now owns 5,704,577 shares of the real estate investment trust’s stock valued at $428,356,000 after buying an additional 392,652 shares during the period. FMR LLC increased its position in National Health Investors by 35.0% in the second quarter. FMR LLC now owns 1,660,500 shares of the real estate investment trust’s stock valued at $124,687,000 after buying an additional 430,500 shares during the period. BlackRock Institutional Trust Company N.A. increased its position in National Health Investors by 6.5% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 1,241,855 shares of the real estate investment trust’s stock valued at $82,608,000 after buying an additional 76,086 shares during the period. BlackRock Fund Advisors increased its position in National Health Investors by 2.0% in the second quarter. BlackRock Fund Advisors now owns 986,833 shares of the real estate investment trust’s stock valued at $74,101,000 after buying an additional 19,017 shares during the period. Finally, GW&K Investment Management LLC increased its position in National Health Investors by 2.9% in the first quarter. GW&K Investment Management LLC now owns 882,994 shares of the real estate investment trust’s stock valued at $58,737,000 after buying an additional 24,639 shares during the period. 68.14% of the stock is owned by institutional investors.

About National Health Investors

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

5 Day Chart for NYSE:NHI

Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.